MANUFACTURER GEN-ONE MVP FOR INITIAL ROLLOUT
CLASS II MEDICAL DEVICE REGULATORY PATHWAY
HOSPITAL SURGEON PREFERENCE TRIALS
FDA 510(K) PREMARKET REGISTRATION
HOSPITAL IRB CLINICAL TRIALS
PROTECT INTELLECTUAL PROPERTY
Having been CEO for several successful companies at this stage, I realize just how important it is to choose the right investor partner. Embracing this, I am ardently looking for a premier value-added private equity investors - not just a source of capital - nor just the typical angle or venture group. I am resolute on only working with a group of investors who, through a non-cookie cutter approach, earnestly offer their experience, knowledge, and support in a way that helps mitigate our risks, amplifies our success, and ultimately helps fulfill our pursuit to:
Profitably save lives by significantly curtailing the 3rd leading cause of death in the United States, preventable medical errors, by ameliorating healthcare system flaws with technology-enabled process innovations.
That said, I recognize the right investor can be so much more than just a source of capital to their portfolio companies, by mentoring, coaching, and sharing their expertise & connections. So, it is my resolve that the investor(s) we choose will demonstrate that they invest in a lot more than just promising products - but in the impactful people who develop them. This is the capital AND wisdom I seek.
CEO & CHAIR
The information you are 'requesting' through this website is being provided to you in your capacity as a potential investor in certain funds (each, a “Fund”) owned or managed by one of its affiliates. The information is provided to you to assist you with respect to your potential investment (“Permitted Purpose”). Some or all of the information being provided to you is confidential and/or non-public information. You hereby agree not to disclose or use such information in a manner that violates any federal or state securities law, rule or regulation, any servicing agreement, or related nonsolicitation guidelines.
Magvation will provide you with access to certain confidential, non-public information regarding your potential investment, and/or certain underlying investment assets (the “Confidential Information”). You acknowledge that the Confidential Information (a) includes or may be based upon information provided by third parties, (b) may not have been verified by Magvation, and (c) may be incomplete or contain inaccuracies. You agree that Magvation shall not have any liability to you or your representatives resulting from any inaccuracies or omissions in the Confidential Information, any of your use of Confidential Information, or Magvation's inability or failure to provide the Confidential Information to you for any reason.
You agree that you will not disclose, and you will take reasonable precautions to prohibit from disclosing the Confidential Information in any manner whatsoever to any other person or entity, other than your representatives (but only to the extent necessary to accomplish the Permitted Purpose) or as otherwise required by applicable law or any governmental agency. You acknowledge that any use or disclosure of the Confidential Information by you or your representatives for any purpose, other than the Permitted Purpose, in addition to being a breach of this agreement and/or a Digital Fund Documentation, may constitute a violation of federal and state securities laws. You will take reasonable precautions to ensure that each representative has notice of its obligations under this agreement and agrees not to violate its terms. The term “representative” with respect to any entity shall mean the officers, directors, general partners, investors, employees, agents, affiliates, auditors and legal counsel for that entity.
Magvation only accepts accredited investors for investment in Magvation under the Securities and Exchange Commission (“SEC”) Rule 506(c) - and will not acknowledge nor accept investment from any fund otherwise, including, but not limited to, Rule 506(C) Exemptions (b) or (d).
Magvation recognizes that most angel networks only accept accredited investors for investment membership - and members do not have to provide personal financial data to Magvation, Inasmuch as any investor is in good standing, and has made reasonable efforts to comply with The Angel Capital Association (ACA) policy criteria to verify respective accredited investor members. (Based on ACA guidance published in September 2013)
Magvation has made reasonable attempts to verify that any potential investors are accredited and that any fund meets the criteria of an Established Angel Group (EAG) as per the following provisions:
1. Private investor group for early-stage companies
2. All members are accredited through self-certification & understand risks associated in this investment class
3. There is a stated code of conduct
4. There is an established deal/ investment process – Angels invest own money or – Angels participate in the group’s investment decision process
5. There is a process for members to affirm accredited status periodically (annually)
6. Group has vetting process for members (fit 3 or more of these): – Recommended/referred by a current member – Interviewed by members or committee – Complete application with individual background – Approved by board or other designated approving authority – Other reasonable vetting (background checks, financial docs, etc. Securities and Exchange Commission (“SEC”) Rule 506(c).